Biochemical and Biophysical Research Communications 1988-02-15

Carboxyethyl gamma-aminobutyric acid, a polyamine derivative, improves the recovery of EBV-transformed lymphocytes.

A Cerino, M Bestagno, M Colonna, F Fussi, G C Astaldi Ricotti

Index: Biochem. Biophys. Res. Commun. 150(3) , 931-6, (1988)

Full Text: HTML

Abstract

A polyamine derivative, carboxyethyl - Aminobutyric Acid (CEGABA), induces the formation of a large number of Epstein-Barr Virus (EBV) transformed lymphocytes, when added to the culture medium immediately after EBV infection. However, CEGABA shows only a moderate effect on the stability of EBV-transformed cell lines over time, and does not affect the growth of stabilized cell lines. It is possible that CEGABA acts on cells other than EBV transformed lymphocytes (in fact, after EBV infection all types of mononuclear cells from the blood are present in the culture) and indirectly promotes the growth of EBV transformed lymphocytes.


Related Compounds

Related Articles:

Carboxyethyl gamma-aminobutyric acid, a polyamine derivative molecule with a growth effect on hybridomas.

1985-03-18

[J. Immunol. Methods 77 , 229, (1985)]

Experimental study on central effects of carboxyethyl-gamma-aminobutyric acid (CEGABA).

1988-04-01

[Farmaco. Sci. 43(4) , 363-72, (1988)]

Identification of N-carboxyethyl gamma-aminobutyric acid in bovine brain and human cerebrospinal fluid.

1987-06-26

[Neurosci. Lett. 77(3) , 308-10, (1987)]

Pharmacological effects of CEGABA, a new aminoacid occurring in mammalian brain.

1987-01-01

[Farmaco. Sci. 42(1) , 77-9, (1987)]

More Articles...